Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Canrenone as Add-on in Patients With Essential Hypertension-Italy (ESCAPE-IT)

NCT02687178 is registered in ClinicalTrials.gov with University of Pavia as lead sponsor.

NCT NCT02687178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02687178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Canrenone as Add-on in Patients With Essential Hypertension-Italy (ESCAPE-IT)
Lead sponsor
University of Pavia
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2010
Completion date
January 31, 2016
Enrollment
180 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension